Influenza Hemagglutinin (HA) Peptide: Precision Epitope Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-amino acid epitope commonly used as a molecular tag in protein detection and purification workflows. This peptide enables competitive binding to anti-HA antibodies, facilitating the elution of HA-tagged proteins during immunoprecipitation and affinity purification (Dong et al., 2025). It displays high solubility in water (≥46.2 mg/mL), ethanol (≥100.4 mg/mL), and DMSO (≥55.1 mg/mL) at room temperature, supporting compatibility with diverse buffers (APExBIO, 2024). The HA tag peptide is supplied at >98% purity, validated by HPLC and mass spectrometry for consistent research performance. APExBIO's A6004 product has been widely adopted for protein interaction studies, especially in workflows interrogating ubiquitin ligase pathways in cancer signaling (see translational catalyst perspective).

Biological Rationale

The HA tag is derived from the epitope region of the human influenza hemagglutinin protein. The nine-amino acid sequence YPYDVPDYA corresponds to a linear epitope recognized with high specificity by monoclonal anti-HA antibodies (Dong et al., 2025). Use of epitope tags, such as the HA peptide, enables detection, immunoprecipitation, and purification of recombinant fusion proteins without relying on native epitopes, streamlining assay standardization across species and constructs (see Revolutionizing Protein Detection). The HA tag system is especially beneficial in probing protein-protein interactions, post-translational modifications (e.g., ubiquitination), and cellular signaling pathways, as exemplified by NEDD4L-mediated PRMT5 regulation in cancer research (Dong et al., 2025).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide functions as a competitive epitope for anti-HA antibodies. When added to immunoprecipitation or affinity purification systems, the free HA peptide competes with HA-tagged fusion proteins for antibody binding. This competition results in the displacement and elution of specifically bound HA-tagged proteins from the antibody–solid support complex (see Transforming Protein Detection Workflows). High solubility ensures efficient peptide delivery and rapid antibody saturation. The competitive binding mechanism enables gentle elution under physiological conditions, preserving protein activity and multiprotein complexes for downstream analysis. The peptide's stability (when stored desiccated at -20°C) and >98% purity guarantee consistent assay performance (APExBIO, 2024).

Evidence & Benchmarks

• The HA peptide sequence (YPYDVPDYA) is specifically recognized by monoclonal anti-HA antibodies, enabling detection and purification of HA-tagged proteins in mammalian and non-mammalian systems (Dong et al., 2025).
• The A6004 peptide from APExBIO demonstrates solubility ≥46.2 mg/mL in water, ≥100.4 mg/mL in ethanol, and ≥55.1 mg/mL in DMSO at 25°C, supporting diverse assay formats (APExBIO, 2024).
• Product purity exceeds 98% as confirmed by HPLC and mass spectrometry, minimizing background and non-specific binding (APExBIO, 2024).
• In immunoprecipitation assays, addition of the HA peptide enables efficient elution of HA-fusion proteins from anti-HA antibody-coated beads without harsh denaturants, facilitating sensitive protein interaction studies (see Optimizing Immunoprecipitation).
• In cancer pathway research, the HA tag system is used to interrogate protein-protein and protein-ubiquitin ligase interactions, as in studies of NEDD4L and PRMT5 in colorectal cancer metastasis (Dong et al., 2025).

Applications, Limits & Misconceptions

The HA tag peptide is widely used for:

• Detection of HA-tagged fusion proteins by immunoblotting, ELISA, and immunofluorescence.
• Affinity purification and immunoprecipitation workflows using anti-HA magnetic beads or antibodies.
• Elution of protein complexes under mild, non-denaturing conditions—critical for mapping protein-protein interactions and post-translational modifications.
• Interrogating ubiquitin ligase pathways in mechanistic cancer research, as in the case of NEDD4L and PRMT5 (Dong et al., 2025).

While the HA tag system is robust, users should be aware of specific boundaries and common errors.

Common Pitfalls or Misconceptions

• Not suitable for denaturing conditions: The competitive elution mechanism requires native antibody-epitope interaction; harsh denaturants disrupt binding.
• Not compatible with all antibodies: Only anti-HA antibodies (monoclonal or polyclonal) with specificity to YPYDVPDYA will support efficient elution.
• Tag accessibility: Epitope accessibility may be reduced in certain protein conformations or when the HA tag is buried within fusion constructs.
• Not a universal tag: The HA tag sequence is not recognized by anti-FLAG, anti-His, or other tag-specific antibodies.
• Does not confer biological activity: The HA tag is inert and does not alter target protein function, localization, or stability on its own.

This article clarifies workflows and assay boundaries compared to Solving Lab Challenges with HA Peptide, by explicitly enumerating compatibility parameters and purity benchmarks.

Workflow Integration & Parameters

The HA tag peptide (A6004) from APExBIO is formulated for rapid dissolution and direct use in standard immunoprecipitation (IP), co-IP, and protein purification workflows. Typical use involves addition of 1–2 mM HA peptide to anti-HA antibody-bound beads for competitive elution at 4–25°C, pH 7.4–8.0. High solubility supports high-concentration stocks for titration-based optimization. For best performance, store the lyophilized peptide desiccated at -20°C; avoid repeated freeze-thaw cycles of prepared solutions. The peptide's compatibility with automated platforms and multiplexed assays accelerates high-throughput screening in proteomics and cell signaling research.

This article updates the translational perspective presented in From Epitope Tag to Translational Catalyst by integrating product-specific solubility and purity metrics essential for experimental reproducibility in advanced cancer pathway analysis.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide (A6004) from APExBIO sets the standard for high-purity, highly soluble epitope tag reagents in molecular biology. Its validated performance in protein detection, affinity purification, and gentle elution workflows underpins both basic and translational research, including mechanistic studies of E3 ligase-mediated cancer signaling. As protein interaction and ubiquitination assays become more complex, standardized reagents like this HA tag peptide are essential for reproducible, high-sensitivity results. For detailed protocols and ordering information, visit the Influenza Hemagglutinin (HA) Peptide product page.